First Midwest Bank Trust Division’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-878
Closed -$342K 388
2021
Q3
$342K Buy
+878
New +$374K 0.05% 297

Other funds holding FNCH

First Midwest Bank Trust Division's FNCH Position: Q4 2021 in Review

First Midwest Bank Trust Division sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2021, closing a stake of 878 shares — an estimated $342K sold.

First Midwest Bank Trust Division first reported a position in FNCH in Q3 2021 and held it in 1 quarter. The position peaked at $342K in Q3 2021. 51 funds tracked by Wall St. Rank hold FNCH as of Q4 2021.

  • First Midwest Bank Trust Division reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 878 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2021, an estimated $342K.
  • First Midwest Bank Trust Division first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • First Midwest Bank Trust Division's Finch Therapeutics Group, Inc. Common Stock position peaked at $342K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.